Dietmar was Chief Medical Officer and Global Head of Development at Sanofi, and Global Head of Research and Development at Atara Biotherapeutics. Dietmar Berger joined Gilead Sciences in 2025.
Dietmar Berger is currently
Create your alert
to follow the career of Dietmar Berger.
Dietmar Berger has a PhD in Human Medicine from Albert-Ludwigs-University.
Do you need to know more about Dietmar Berger? More results.
Report an error
Update the org chart details of Dietmar Berger.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.